Optimization of the expression of serine proteases in host cells
The present invention relates to a method for the recombinant production of a serine protease comprising (a) culturing a host cell comprising one or more vectors, wherein the one or more vectors encode in expressible form the serine protease and a proteinaceous inhibitor of the serine protease, wherein the proteinaceous inhibitor of the serine protease is heterologous with respect to the serine protease, under conditions wherein the serine protease and the proteinaceous inhibitor of the serine protease are expressed; or (a′) culturing a host cell the genome of which encodes in expressible form the serine protease and a proteinaceous inhibitor of the serine protease, wherein the proteinaceous inhibitor of the serine protease is heterologous with respect to the serine protease, and wherein the coding sequences of the serine protease and/or the proteinaceous inhibitor have been introduced into the host cell genome by applying a CRISPR technology, under conditions wherein the serine protease and the proteinaceous inhibitor of the serine protease are expressed; and (b) isolating the serine protease expressed in step (a) or (a′) from the host cell. The present invention also relates to a host cell comprising one or more vectors, wherein the one or more vectors encode in expressible form a serine protease and a proteinaceous inhibitor of the serine protease.
1. A method for the recombinant production of debrilase comprising
(a) culturing a host cell comprising one or more vectors, wherein the one or more vectors encode in expressible form debrilase and a proteinaceous inhibitor of debrilase under conditions wherein debrilase and the proteinaceous inhibitor of debrilase are expressed; or
(a′) culturing a host cell the genome of which encodes in expressible form debrilase and a proteinaceous inhibitor of debrilase wherein the coding sequences of debrilase and/or the proteinaceous inhibitor have been introduced into the host cell genome under conditions wherein debrilase and the proteinaceous inhibitor of debrilase are expressed; and
(b) isolating debrilase expressed in step (a) or (a′),
wherein the proteinaceous inhibitor of debrilase is selected from the group consisting of aprotinin, plasminostreptin (I16.001), proteinase inhibitor type-2 K (PIN2K, I20.001), ecotin (I11.001), trypsin inhibitor MCTI-1 (I07.001), ascidian trypsin inhibitor (I05.001), peptidase inhibitor 5 (KappaPI-actitoxin-Avd3a, I02.026), and tissue factor pathway inhibitor-2 inhibitor unit 1 (TFPI2, I02.013).
2. The method of claim 1 , wherein debrilase is isolated in step (b) by size-exclusion chromatography, ion-exchange chromatography, affinity chromatography, or hydrophobic interaction chromatography.
3. The method of claim 1 further comprising (c) proteolytically processing the isolated debrilase.
4. A host cell
(i) comprising one or more vectors, wherein the one or more vectors encode in expressible form debrilase and a proteinaceous inhibitor of debrilase, or
(ii) the genome of which encodes in expressible form debrilase and a proteinaceous inhibitor of debrilase, wherein the coding sequences of debrilase and/or the proteinaceous inhibitor have been introduced into the host cell genome,
wherein the proteinaceous inhibitor of debrilase is selected from the group consisting of aprotinin, plasminostreptin (I16.001), proteinase inhibitor type-2 K (PIN2K, I20.001), ecotin (I11.001), trypsin inhibitor MCTI-1 (I07.001), ascidian trypsin inhibitor (I05.001), peptidase inhibitor 5 (KappaPI-actitoxin-Avd3a, I02.026), and tissue factor pathway inhibitor-2 inhibitor unit 1 (TFPI2, I02.013).
5. The method of claim 1 , wherein the host cell is
(a) a yeast cell;
(b) a bacterial cell; or
(c) a filamentous fungal cell.
6. The method of claim 1 , wherein in the one or more vectors, debrilase is expressed from a first expression cassette and the proteinaceous inhibitor of debrilase is expressed from a second expression cassette.
7. The method of claim 6 , wherein debrilase and the proteinaceous inhibitor of debrilase are under the control of the same or different regulated promoter(s).
8. The method of claim 7 , wherein debrilase is under the control of the same regulated promoter as the proteinaceous inhibitor of debrilase.
9. The method of claim 8 , wherein the host cell is a Pichia pastoris cell.
10. The method of claim 3 , wherein proteolytically processing comprises the release of a propeptide from debrilase by proteolytic cleavage.
11. The method of claim 1 , wherein the proteinaceous inhibitor of debrilase is aprotinin.
12. The host cell of claim 4 , wherein the proteinaceous inhibitor of debrilase is aprotinin.
13. The method of claim 5 , wherein:
(a) the yeast cell is a Pichia pastoris cell;
(b) the bacterial cell is a Escherichia coli or a Bacillus subtilis cell; and
(c) the filamentous fungal cell is an Aspergillus cell.
14. The method of claim 6 , wherein the first and second expression cassettes are on two separate vectors.
15. The host cell of claim 4 , wherein in the one or more vectors, debrilase is expressed from a first expression cassette and the proteinaceous inhibitor of debrilase is expressed from a second expression cassette.
16. The host cell of claim 15 , wherein debrilase is under the control of the same regulated promoter as the proteinaceous inhibitor of debrilase.
17. The host cell of claim 15 , wherein the first and second expression cassettes are on two separate vectors.
18. The method of claim 9 , wherein the regulated promoter is P aox (alcohol oxidase promoter).
19. The method of claim 18 , wherein the regulated promoter is P aox1 or P aox2 .